SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
CVTX - CV Therapeutics, Inc.
An SI Board Since January 1999
Posts SubjectMarks Bans
411 31 0
Emcee:  Todd N. Weisrock Type:  Unmoderated
Introduction Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
336citi: CV Therapeutics Inc (CVTX) Company Making Progress; Increasing TP To $11 mopgcw-4/28/2008
335CV Therapeutics Reports 2008 First Quarter Financial Results Friday April 25, 7:mopgcw-4/25/2008
334M-Fool: CVT's Copacetic Cash Management By Brian Lawler April 17, 2008 Itmopgcw-4/24/2008
333European Medicines Agency Adopts Positive Opinion for Ranolazine for Treatment omopgcw-4/24/2008
332CV Therapeutics shares jump on drug rights deal Wednesday April 16, 1:42 pm ET Ctnsaf-4/16/2008
331CV Therapeutics' Anti-Ischemic Therapy Ranexa(R) Significantly Reduces Cardimopgcw-4/1/2008
330Citi 2.26.08: Conclusion — We are decreasing our target price to $9 from $11. Wmopgcw-4/1/2008
329Ranolazine Shortens QT Interval and Improves Cardiac Relaxation in Study of Patimopgcw-3/31/2008
328UPDATE 1-CV Therapeutics awaiting FDA regadenoson decision Fri Mar 14, 2008 4:44mopgcw-3/14/2008
327apparently 3rd Point bailed a bunch of shares too..mopgcw-2/29/2008
326MOT FOOL: Feeling Good About CV Therapeutics By Brian Lawler February 28, 2008 mopgcw-2/29/2008
325CV Therapeutics Reports 2007 Fourth Quarter and Full Year Financial Results Tuesmopgcw-2/27/2008
324CV Therapeutics and Medlogics Device Corporation Sign Licensing Agreement for CVmopgcw-2/4/2008
323Oh, right. That one probably isn't worth $30 million in MC. I had tuned outuck-12/18/2007
322BT stock prices are vulnerable to good news these days, but this isn't the lkeokalani'nui-12/18/2007
321>> FDA Approves New Mechanism of Action Labeling for Ranexa(R) Tuesday Dectuck-12/18/2007
320CV Therapeutics Reports 2007 Third Quarter Financial Results Tuesday November 6,mopgcw-11/7/2007
319CV Therapeutics Announces Presentations at American Heart Association Scientificmopgcw-10/23/2007
318mstar: CVTX announced Thursday that it has submitted its flagship drug, Ranexa,mopgcw-9/28/2007
317CV Therapeutics Submits Supplemental New Drug Application for Ranexa(R) (ranolazkeokalani'nui-9/27/2007
316CV Therapeutics' Ranexa Reduces Erratic Heart Rates (Update1) 2007-09-05 16:mopgcw-9/14/2007
315I went long some stock and April calls. $9.60keokalani'nui-9/11/2007
314Legged out of the straddle yesterday and today. A few days after I added, the vtuck-9/6/2007
313>>PHARMA MARKET: CV's Chest Pain Drug Ranexa Has Slow Start Last updattuck-8/30/2007
312>>keep in mind they hired some bankers a while back...that would be about tuck-8/24/2007
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News